Phenotypic and genotypic landscape of antibiotic resistance through One Health approach in Sri Lanka: A systematic review.

Thilini Nisansala, Yasodhara Deepachandi Gunasekara, Nadisha Sewwandi Piyarathne
Author Information
  1. Thilini Nisansala: Faculty of Veterinary Medicine, Universiti Malaysia Kelantan, Malaysia. ORCID
  2. Yasodhara Deepachandi Gunasekara: Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, University of Melbourne, Parkville, Victoria, Australia. ORCID
  3. Nadisha Sewwandi Piyarathne: Institute of Dentistry, School of Medicine Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK. ORCID

Abstract

OBJECTIVES: Antibiotic resistance (ABR) constitutes a significant burden to economies in developing countries. In the 'One-Health' concept, ABR in human, animals, and environment is interconnected. The aim of this study was to critically appraise literature on ABR in all three domains in One Health, within the Sri Lankan geographical context.
METHODS: The protocol was registered with PROSPERO and followed PRISMA 2020 guidelines. A comprehensive electronic literature search was conducted in PubMed, Scopus, Web of Science databases and grey literature via Google Scholar. Out of 298 abstracts, 37 articles were selected following screening. A risk of bias assessment was conducted using Joanna Briggs Institute tools. Following blinded data extraction, descriptive data analysis and narrative synthesis were performed.
RESULTS: This review included studies published between 2016-2023. Of the included studies, 17 (45.9%) reported data on samples obtained from humans, 9 (24.3%) from animals, and 6 (16.2%) from environmental sources, two studies (5.4%) from humans and animals, one study on animal and environment; whereas two studies including all three domains. ABR of 32 different bacteria (Gram negative���17, Gram positive���14) was retrieved; E. coli was the most frequently studied bacteria followed by MRSA and ESBL. For E. coli, a median resistance over 50% was reported for sulfamethoxazole (88.8%), trimethoprim (79.1%), ampicillin (60%) and tetracycline (50.3%) with the highest resistance for erythromycin (98%). Of a total of 21 antibiotic-resistance genes in E. coli, the highest genotypic resistance was for tet-A (48.5%).
CONCLUSIONS: A comprehensive description of ABR for a total of 32 bacteria, 62 antibiotics and 46 ABR genes is presented. This review discusses the contemporary ABR landscape in Sri Lanka through the One Health lens, highlighting key methodological and empirical research gaps.

Keywords

References

  1. Germs. 2017 Sep 1;7(3):132-139 [PMID: 28932713]
  2. Lancet. 2022 Feb 12;399(10325):629-655 [PMID: 35065702]
  3. Ceylon Med J. 2019 Dec 31;64(4):140-145 [PMID: 32120467]
  4. Pathogens. 2022 Mar 23;11(4): [PMID: 35456061]
  5. Int J Surg. 2021 Apr;88:105906 [PMID: 33789826]
  6. Molecules. 2020 Jun 23;25(12): [PMID: 32586045]
  7. Proc Biol Sci. 2018 Apr 11;285(1876): [PMID: 29643217]
  8. Can J Infect Dis Med Microbiol. 2021 Jun 02;2021:5153237 [PMID: 34122680]
  9. Indian J Med Microbiol. 2022 Oct-Dec;40(4):505-509 [PMID: 36031499]
  10. J Pediatric Infect Dis Soc. 2015 Mar;4(1):11-20 [PMID: 26407352]
  11. J Glob Antimicrob Resist. 2019 Mar;16:17-27 [PMID: 30145271]
  12. Infect Drug Resist. 2019 May 08;12:1181-1197 [PMID: 31190907]
  13. Indian J Med Microbiol. 2023 Mar-Apr;42:71-76 [PMID: 36400647]
  14. Antibiotics (Basel). 2023 Feb 23;12(3): [PMID: 36978313]
  15. Chemosphere. 2021 Sep;279:130591 [PMID: 33894511]
  16. Microbiol Insights. 2023 Jan 12;16:11786361221145179 [PMID: 36655025]
  17. BMC Infect Dis. 2016 Oct 26;16(1):607 [PMID: 27782812]
  18. Int J Infect Dis. 2022 Jun;119:120-129 [PMID: 35358724]
  19. Microorganisms. 2021 Oct 06;9(10): [PMID: 34683427]
  20. Open Med (Wars). 2023 May 12;18(1):20230707 [PMID: 37197355]
  21. S Afr Med J. 2015 Apr 06;105(5):325 [PMID: 26242647]
  22. Biomed Res Int. 2023 Feb 1;2023:2425564 [PMID: 36778056]
  23. Lancet. 2024 Sep 28;404(10459):1199-1226 [PMID: 39299261]
  24. Vaccine. 2020 Oct 27;38(46):7308-7315 [PMID: 32981783]
  25. Front Microbiol. 2018 Aug 31;9:2044 [PMID: 30233529]
  26. Int J Antimicrob Agents. 2017 Nov;50(5):629-639 [PMID: 28705671]
  27. J Lab Physicians. 2019 Jan-Mar;11(1):34-38 [PMID: 30983800]
  28. Antimicrob Resist Infect Control. 2021 Apr 30;10(1):72 [PMID: 33931120]
  29. Environ Res. 2020 Apr;183:109179 [PMID: 32006770]
  30. One Health. 2022 Nov 19;15:100465 [PMID: 36561710]
  31. Foodborne Pathog Dis. 2019 Jul;16(7):531-537 [PMID: 31099590]
  32. BMC Infect Dis. 2018 Jul 28;18(1):351 [PMID: 30055584]
  33. PLoS Med. 2024 Mar 14;21(3):e1004301 [PMID: 38484006]
  34. BMC Infect Dis. 2017 Sep 11;17(1):616 [PMID: 28893183]
  35. Heliyon. 2023 May 19;9(6):e16123 [PMID: 37274713]
  36. Eur J Public Health. 2024 Oct 1;34(5):885-889 [PMID: 38578613]
  37. Antimicrob Resist Infect Control. 2023 Jul 13;12(1):69 [PMID: 37443104]
  38. J Wildl Dis. 2022 Apr 1;58(2):380-383 [PMID: 35276733]
  39. Antimicrob Agents Chemother. 2017 Dec 21;62(1): [PMID: 29038269]
  40. Epidemiol Infect. 2024 Feb 12;152:e33 [PMID: 38343135]
  41. Med Princ Pract. 2023;32(2):126-132 [PMID: 37023724]
  42. Int J Antimicrob Agents. 2023 Aug;62(2):106848 [PMID: 37201798]
  43. J Infect Dev Ctries. 2023 Apr 30;17(4):500-506 [PMID: 37159888]
  44. Lancet Glob Health. 2023 Mar;11(3):e466-e474 [PMID: 36739875]
  45. Antibiotics (Basel). 2019 Aug 26;8(3): [PMID: 31454985]
  46. Antimicrob Resist Infect Control. 2023 Mar 3;12(1):15 [PMID: 36869351]
  47. Antibiotics (Basel). 2021 Jan 19;10(1): [PMID: 33477994]
  48. AIMS Microbiol. 2023 Feb 13;9(1):75-89 [PMID: 36891533]
  49. Trop Med Int Health. 2025 Mar;30(3):143-158 [PMID: 39763328]
  50. J Glob Antimicrob Resist. 2020 Sep;22:488-496 [PMID: 32348900]
  51. J Glob Antimicrob Resist. 2022 Sep;30:115-122 [PMID: 35667644]
  52. Clin Microbiol Rev. 2007 Apr;20(2):368-89 [PMID: 17428889]
  53. BMC Infect Dis. 2017 Jul 11;17(1):490 [PMID: 28697755]
  54. BMC Public Health. 2019 Aug 19;19(1):1135 [PMID: 31426792]
  55. J Wildl Dis. 2019 Oct;55(4):879-884 [PMID: 31021685]
  56. Environ Res. 2020 Sep;188:109765 [PMID: 32554273]
  57. Chemotherapy. 2024;69(1):56-64 [PMID: 37673044]
  58. PLoS One. 2021 Sep 14;16(9):e0257424 [PMID: 34520501]
  59. Antibiotics (Basel). 2013 Apr 18;2(2):237-55 [PMID: 27029301]
  60. BMC Infect Dis. 2021 Jun 15;21(1):578 [PMID: 34130629]
  61. BMC Infect Dis. 2017 Feb 10;17(1):138 [PMID: 28187754]

MeSH Term

Sri Lanka
Humans
One Health
Anti-Bacterial Agents
Animals
Phenotype
Genotype
Drug Resistance, Bacterial
Drug Resistance, Microbial

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0ABRresistanceOneHealthSrireviewstudiesanimalsliteraturedatabacteriaEcolienvironmentstudythreedomainsfollowedcomprehensiveconductedincludedreportedhumans3%two32GramhighesttotalgenesgenotypiclandscapeLankaantibioticsystematicOBJECTIVES:Antibioticconstitutessignificantburdeneconomiesdevelopingcountries'One-Health'concepthumaninterconnected TheaimcriticallyappraisewithinLankangeographicalcontextMETHODS:protocolregisteredPROSPEROPRISMA2020guidelineselectronicsearchPubMedScopusWebSciencedatabasesgreyviaGoogleScholar298abstracts37articlesselectedfollowingscreeningriskbiasassessmentusingJoannaBriggsInstitutetoolsFollowingblindedextractiondescriptiveanalysisnarrativesynthesisperformedRESULTS:published2016-202317459%samplesobtained9246162%environmentalsources54%oneanimalwhereasincludingdifferentnegative���17positive���14retrievedfrequentlystudiedMRSAESBLmedian50%sulfamethoxazole888%trimethoprim791%ampicillin60%tetracycline50erythromycin98%21antibiotic-resistancetet-A485%CONCLUSIONS:description62antibiotics46presenteddiscussescontemporarylenshighlightingkeymethodologicalempiricalresearchgapsPhenotypicapproachLanka:

Similar Articles

Cited By